Less Ads, More Data, More Tools Register for FREE

Pin to quick picksECM.L Regulatory News (ECM)

  • There is currently no data for ECM

Trading Statement

12 Apr 2022 07:00

RNS Number : 0315I
Electrocomponents PLC
12 April 2022
 

12 April 2022, 7.00am

 

Electrocomponents plc today issues a trading update for the year ended 31 March 2022, ahead of publishing full-year results on 24 May 2022

 

Like-for-like revenue growth1

Region

Q1 toJun 2021

Q2 toSep 2021

Q3 toDec 2021

Q4 toMar 2022

Year to Mar 2022

EMEA

37%

22%

14%

19%

22%

Americas

40%

35%

37%

33%

36%

Asia Pacific

31%

31%

25%

23%

27%

Group

37%

26%

21%

23%

26%

 

 

Group like-for-like revenue growth for the year ended 31 March 2022 was 26%. Please refer to our commentary accompanying the recent trading update released on 9 March 2022 for more detail. As reported on 30 March 2022, we expect our full year adjusted operating profit margin to be at the top end of the consensus range2. Due to our trading update on 9 March 2022 and Investor Event on 30 March 2022, there will be no conference call taking place today. Webcasts from both are on our website www.electrocomponents.com/investors/financial-results.

 

As previously announced, in early May Electrocomponents plc will become RS Group plc as we strengthen our position as one brand, united behind our single purpose of 'making amazing happen for a better world'. An announcement will be made when the name change becomes effective with a revised stock TIDM (ticker). Until such an announcement is made, trading will continue under the existing ticker 'ECM'. No action is required on the part of any shareholder.

 

 

Enquiries:

David Egan

Chief Financial Officer

020 7239 8400

Lucy Sharma

VP Investor Relations

020 7239 8427

Martin Robinson / Olivia Peters

Tulchan Communications

020 7353 4200

 

Notes:

1. Like-for-like revenue growth is growth in revenue adjusted to eliminate the impact of acquisitions and the effects of changes in exchange rates and trading days year on year. Acquisitions are only included once they have been owned for a year, at which point they start to be included in both the current and comparative periods for the same number of months. 2020/21 is converted at 2021/22 average exchange rates for the period.  

2. Consensus for the year ended 31 March 2022 (as reported on 30 March 2022) of adjusted profit before tax of £306.0 million within a range of £299.9 million to £313.0 million (source: Electrocomponents.com/investors/analyst-coverage).

3. Our profit remains sensitive to movements in exchange rates on translation of overseas profits. Average exchange rates for the year ended 31 March 2022 for euro and US dollar were €1.176 and $1.366 respectively. Every 1 cent movement in the euro has a c. £1.8 million impact on annual adjusted profit before tax. Every 1 cent movement in the US dollar has a c. £0.7 million impact on annual adjusted profit before tax.  

4. We expect to see a negative impact of around £7 million on revenue from fewer trading days in 2022/23 compared to 2021/22.  

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFEDSIILLIF
Date   Source Headline
2nd Feb 200910:51 amRNSBlocklisting Interim Review
27th Jan 200911:12 amRNSHolding(s) in Company
19th Jan 20093:18 pmRNSHolding(s) in Company
19th Jan 20092:40 pmRNSHolding(s) in Company
22nd Dec 20087:00 amRNSInterim Management Statement
11th Nov 20087:00 amRNSInterim Results
3rd Nov 20082:41 pmRNSTotal Voting Rights
3rd Oct 20083:39 pmRNSHolding(s) in Company
2nd Oct 200812:07 pmRNSHolding(s) in Company
1st Oct 20089:40 amRNSTotal Voting Rights
23rd Sep 20081:34 pmRNSNotice of Results
4th Sep 20081:06 pmRNSDirector/PDMR Shareholding
2nd Sep 200812:54 pmRNSTotal Voting Rights
22nd Aug 200810:28 amRNSHolding(s) in Company
15th Aug 20081:39 pmRNSHolding(s) in Company
13th Aug 200811:07 amRNSHolding(s) in Company
1st Aug 20083:08 pmRNSBlocklisting Interim Review
29th Jul 20082:01 pmRNSDirector/PDMR Shareholding
29th Jul 200810:32 amRNSHolding(s) in Company
22nd Jul 20082:34 pmRNSHolding(s) in Company
18th Jul 20082:28 pmRNSResult of AGM
18th Jul 20087:00 amRNSInterim Management Statement
10th Jul 200812:09 pmRNSDirector/PDMR Shareholding
9th Jul 200811:14 amRNSAnnual Information Update
8th Jul 20089:45 amRNSNotice of IMS
4th Jul 200812:05 pmRNSHolding(s) in Company
1st Jul 20083:52 pmRNSHolding(s) in Company
27th Jun 200812:16 pmRNSHolding(s) in Company
26th Jun 200810:32 amRNSHolding(s) in Company
19th Jun 20084:19 pmRNSAnnual Report and Accounts
19th Jun 20081:13 pmRNSHolding(s) in Company
28th May 20087:00 amRNSFinal Results
21st May 20083:05 pmRNSHolding(s) in Company
9th May 200810:43 amRNSHolding(s) in Company
8th May 20082:59 pmRNSNotice of Results
23rd Apr 200812:55 pmRNSHolding(s) in Company
4th Mar 20083:07 pmRNSHolding(s) in Company
3rd Mar 200811:32 amRNSDirectorate Change
19th Feb 20082:44 pmRNSHolding(s) in Company
14th Feb 20087:01 amRNSInterim Management Statement
8th Feb 20081:56 pmRNSHolding(s) in Company
30th Jan 200810:17 amRNSNotice of IMS
29th Jan 20083:12 pmRNSHolding(s) in Company
3rd Jan 20082:46 pmRNSTotal Voting Rights
18th Dec 200711:24 amRNSHolding(s) in Company
4th Dec 20074:50 pmRNSHolding(s) in Company
4th Dec 200712:33 pmRNSTotal Voting Rights
30th Nov 20073:35 pmRNSHolding(s) in Company
28th Nov 20074:16 pmRNSDoc re. Half Yearly Report
22nd Nov 200711:24 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.